Premium
Letter: comparative efficacy of biological therapy in patients with ulcerative colitis
Author(s) -
Singh S.,
Garg S. K.,
Wang Z.,
Murad M. H.,
Loftus E. V.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12760
Subject(s) - vedolizumab , medicine , infliximab , ulcerative colitis , adalimumab , meta analysis , odds ratio , gastroenterology , surgery , tumor necrosis factor alpha , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom